Vimarsana
Biggest News Aggregation in the World

Certain Limitations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Certain Limitations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Certain Limitations Today - Breaking & Trending Today

New Songs: Megan Thee Stallion, Phish, DIIV & more - Vimarsana News

New Songs: Megan Thee Stallion, Phish, DIIV & more

Plus: new songs by Idaho, Anthony Green, Umbra Vitae, Marina Allen, and more.

Luke Temple and The Cascading Moms announce debut album, share "I Can Dream" - Vimarsana News

Luke Temple and The Cascading Moms announce debut album, share "I Can Dream"

Luke Temple of Here We Go Magic and Art Feynman has a new group, Luke Temple & The Cascading Moms, who will release their debut album on July 19

Subscription, professional and training services doesn't qualify as FTS under India-Netherland DTAA - Vimarsana News

Subscription, professional and training services doesn't qualify as FTS under India-Netherland DTAA

ITAT Delhi held that income from subscription, professional and training services for use of software doesn’t fall within the definition of Fees for Technical Services (FTS) under India-Netherlands DTAA and hence cannot be taxed in India.

Source: taxguru.in
Pres. Biden Begins Taking Newly FDA-Authorized Drug, Paxlovid, after Testing Positive for COVID - Vimarsana News

Pres. Biden Begins Taking Newly FDA-Authorized Drug, Paxlovid, after Testing Positive for COVID

President Joe Biden tested positive for COVID-19 and has begun taking Paxlovid, a newly-authorized treatment for patients who are at high-risk from the virus (such as the elderly), the White House announced on Thursday.

FDA Greenlights Pharmacists to Prescribe COVID-19 Drug Paxlovid | Epstein Becker & Green - Vimarsana News

FDA Greenlights Pharmacists to Prescribe COVID-19 Drug Paxlovid | Epstein Becker & Green

Questions Remain for Pharmacy Test-to-Treat Programs Last week, the U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA) for Paxlovid to authorize...